COVID-19 ARDS Patients Added to Healios ONE-BRIDGE Study – Yahoo Finance

TOKYO, April 14, 2020 /PRNewswire/ -- HEALIOS K.K. ("Healios") continues to make enrolment progress in its ONE-BRIDGE study, a phase II clinical trial in Japan evaluating the safety and efficacy of HLCM051*1, a somatic stem cell regenerative medicine therapy, for pneumonia-induced Acute Respiratory Distress Syndrome (ARDS) *2. As announced on March 26, 2020, Healios has been in discussions with medical specialists and the Pharmaceuticals and Medical Devices Agency (PMDA) regarding the inclusion of pneumonia-induced ARDS patients infected with the novel coronavirus, "We hereby inform you that we have decided to make a protocol change to the ONE-BRIDGE study to include these patients in the ongoing trial

Read more
Induced pluripotent stem cell | biology | Britannica

Induced pluripotent stem cell (iPS cell), immature cell that is generated from an adult (mature) cell and that has regained the capacity to differentiate into any type of cell in the body. Induced pluripotent stem cells (iPS cells) differ from embryonic stem cells (ES cells), which form the inner cell mass of an embryo but also are pluripotent, eventually giving rise to all the cell types that make up the body.

Read more
Induced pluripotent stem cell – Wikipedia

Pluripotent stem cell generated directly from a somatic cell Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from a somatic cell. The iPSC technology was pioneered by Shinya Yamanakas lab in Kyoto, Japan, who showed in 2006 that the introduction of four specific genes (named Myc, Oct3/4, Sox2 and Klf4) encoding transcription factors could convert somatic cells into pluripotent stem cells.[1] He was awarded the 2012 Nobel Prize along with Sir John Gurdon "for the discovery that mature cells can be reprogrammed to become pluripotent."[2] Pluripotent stem cells hold promise in the field of regenerative medicine.[3] Because they can propagate indefinitely, as well as give rise to every other cell type in the body (such as neurons, heart, pancreatic, and liver cells), they represent a single source of cells that could be used to replace those lost to damage or disease.

Read more
Induced Pluripotent Stem Cells (iPS) | UCLA Broad Stem …

iPSC are derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. For example, iPSC can be prodded into becoming beta islet cells to treat diabetes, blood cells to create new blood free of cancer cells for a leukemia patient, or neurons to treat neurological disorders. In late 2007, a BSCRC team of faculty, Drs.

Read more
Stem Cell Basics VI. | stemcells.nih.gov

Induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to an embryonic stem celllike state by being forced to express genes and factors important for maintaining the defining properties of embryonic stem cells. Although these cells meet the defining criteria for pluripotent stem cells, it is not known if iPSCs and embryonic stem cells differ in clinically significant ways

Read more
Induced Pluripotent Stem Cells: Problems and Advantages …

Acta Naturae. 2010 Jul; 2(2): 1828. Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences Research Center of Clinical and Experimental Medicine, Siberian Branch, Russian Academy of Medical Sciences Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences Research Center of Clinical and Experimental Medicine, Siberian Branch, Russian Academy of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Read more